Evidence map›Paper›PMID 40700313›Full record

ArticleMethods and protocols2025

Formation and Characterization of Two Magnetic Three-Dimensional Spheroid Models of Murine Pancreatic Adenocarcinoma.

Magali Perier, Litan Wang, Marine Simonneau, Jacqueline Ngo-Reymond, Julie Guillermet-Guibert, Maxime Lafond, Cyril Lafon

Abstract read
In one paragraph

Article in Methods and protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Magali PerierLabTAU, INSERM, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69003 Lyon, France.ORCID 0009-0005-3063-3778
Litan WangLabTAU, INSERM, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69003 Lyon, France.
Marine SimonneauLabTAU, INSERM, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69003 Lyon, France.
Jacqueline Ngo-ReymondLabTAU, INSERM, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69003 Lyon, France.ORCID 0009-0000-3056-1077
Julie Guillermet-GuibertCentre de Recherches en Cancérologie de Toulouse (CRCT), CNRS-Inserm, Université de Toulouse, 2 av Hubert Curien, 31037 Toulouse, France.ORCID 0000-0003-3173-4907
Maxime LafondLabTAU, INSERM, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69003 Lyon, France.ORCID 0000-0001-8954-9099
Cyril LafonLabTAU, INSERM, Centre Léon Bérard, Université Claude Bernard Lyon 1, 69003 Lyon, France.ORCID 0000-0003-1550-970X

Funding

ITMO cancer PCSI 2020 callLabEx DEVweCAN ANR-10-LABX-006
6 · The paper itself

Abstract

Pancreatic adenocarcinoma remains one of the deadliest cancers, with limited treatment options and high chemoresistance. Traditional 2D cell cultures fail to accurately replicate the tumor architecture. Our study introduces three-dimensional (3D) pancreatic adenocarcinoma spheroid models using magnetic aggregation of pancreatic cancer cells and immortalized fibroblasts in either liquid culture medium or embedded in hydrogels. The spheroids' growth was characterized using optical imaging, while viability was assessed using ATP quantification and flow cytometry. Results demonstrated successful spheroid formation and growth. Further analysis suggested that on one hand, culture in liquid medium and ATP-based viability assessment are practical for initial experiments. On the other hand, hydrogel culture and flow cytometry, although being more resource- and labor-intensive, provided both a more reproducible and detailed viability analysis.

Indexed as

magnetic aggregationpancreatic adenocarcinomaspheroid

Identifiers

PMID40700313
PMCPMC12286017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.